This suggests that our new pathway for initiating anticoagulation in ED patients discharged with a diagnosis of AF is safe and effective. The pathway was a low- tech intervention, which… Click to show full abstract
This suggests that our new pathway for initiating anticoagulation in ED patients discharged with a diagnosis of AF is safe and effective. The pathway was a low- tech intervention, which we believe could be implemented in other EDs. We do not have a comparison group, so we cannot compare these clinical outcomes with those with standard care or alterna-tive pathways. In conclusion, our simple pathway facilitated anticoagulation initi-ation for ED patients with AF at risk of stroke, with a low adverse event rate at 90 days.
               
Click one of the above tabs to view related content.